NeuroStar TMS

Epstein, C

NeuroStar TMS Therapy® is approved by the United States Food and Drug Administration (FDA) for the treatment of major depression in patients with depression who have not benefited from prior antidepressant medication. The NeuroStar TMS Therapy System® uses highly focused, very short, repetitive pulses of magnetic energy to penetrate the skull and stimulate nerve cells in brain regions believed to be linked to depression. NeuroStar TMS Therapy® is non-invasive and the amount of electricity generated in the brain cannot be felt so the patient does not require anesthesia or sedation and can resume normal activities immediately after treatment.